Priya Dayananth

Title: Innovations by Priya Dayananth

Introduction

Priya Dayananth is an accomplished inventor based in Summit, NJ (US). She has made significant contributions to the field of cancer treatment through her innovative research and patents. With a total of two patents to her name, Priya is recognized for her work in utilizing biomarkers for monitoring cancer treatment.

Latest Patents

Priya's latest patents focus on the use of IL-8 as a biomarker in cancer treatment. The first patent describes methods for using IL-8 levels as a determinant of a cancer's responsivity to treatment. This application highlights the potential of IL-8 in assessing tumor size during the course of treatment with anti-cancer agents, such as ERK inhibitors. The second patent also emphasizes IL-8 as a biomarker for monitoring cancer treatment with specific ERK inhibitors, further showcasing her innovative approach to improving cancer therapies.

Career Highlights

Priya Dayananth is currently employed at Merck Sharp & Dohme Corporation, where she continues to advance her research in cancer treatment. Her work has garnered attention in the scientific community, and she is recognized for her contributions to the understanding of cancer biomarkers.

Collaborations

Priya collaborates with notable colleagues, including Ahmed Abdi Samatar and Brian Long. These partnerships enhance her research efforts and contribute to the development of innovative cancer treatment strategies.

Conclusion

Priya Dayananth's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. Her patents and research are paving the way for more effective therapies, demonstrating her commitment to improving patient outcomes.